Philip D. Gregory, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 5,553 shares at $44.76 ($250K) on 2021-01-06, disclosed to the SEC on 2021-01-08.
Seasonal sale ($250k) by Chief Scientific Officer — this insider has traded BLUE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.95 | 45 | $2K | 0.8% |
| 2 | $44.76 | 1,602 | $72K | 28.7% |
| 3 | $44.76 | 1,602 | $72K | 28.7% |
| 4 | $45.46 | 1,152 | $52K | 20.9% |
| 5 | $45.46 | 1,152 | $52K | 20.9% |
| Total | $45.05 avg | 5,553 |
| $250K |
| 100% |
| Filing → |
| TSVT | SELL | 2023-08-24 | $34K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $24K | — | Filing → |
| TSVT | SELL | 2023-01-18 | $11K | — | Filing → |